1. AODWE-004 Maintenance of quality of life improvement in a phase 3 study of tofacitinib for patients with moderately to severely active ulcerative colitis. (17th June 2017) Authors: Panés, J; Rubin, DT; Vermeire, S; Lindsay, JO; Sands, BE; Su, C; Friedman, G; Zhang, H; Kayhan, C; Manuchehri, A; Healey, P Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗